Ozempic is the brand name for semaglutide manufactured by Novo Nordisk, FDA-approved for type 2 diabetes (2017).

How is Ozempic different from Wegovy?

Same active ingredient (semaglutide). Ozempic is labeled for T2D (max 2.0 mg); Wegovy is labeled for chronic weight management and CV risk reduction (max 2.4 mg).

Ozempic — Drug Reference, Dosing, Trials

Ozempic

Released: January 15, 2026Last reviewed: October 15, 2026

Brand name for semaglutide, FDA-approved for type 2 diabetes mellitus. Same active ingredient as Wegovy and Rybelsus.

By Novo NordiskUpdated 2026-05-25

Researched By

Dr. Parmis

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Ozempic overview

Brand name for semaglutide, FDA-approved for type 2 diabetes mellitus. Same active ingredient as Wegovy and Rybelsus.

Ozempic at a glance

Manufacturer

Novo Nordisk

FDA status

FDA-approved

Clinical research overview
Compare GLP-1 forms
Compounded vs brand
NexLife (Editor's #1)

Ozempic

Ozempic overview

Ozempic at a glance

Related pages